Rural Health
Resources by Topic: Vaccination
Facilitators and Barriers of HPV Vaccination: A Qualitative Study in Rural Georgia
Presents findings from interviews with 40 parents and young adults in rural southwest Georgia on attitudes, knowledge, and preferences related to human papillomavirus (HPV) vaccination uptake. Discusses challenges and opportunities related to transportation, knowledge, trust, and stigma.
Author(s): Courtney N. Petagna, Stephen Perez, Erica Hsu, et al.
Citation: BMC Cancer, 24, 592
Date: 05/2024
Type: Document
view details
Presents findings from interviews with 40 parents and young adults in rural southwest Georgia on attitudes, knowledge, and preferences related to human papillomavirus (HPV) vaccination uptake. Discusses challenges and opportunities related to transportation, knowledge, trust, and stigma.
Author(s): Courtney N. Petagna, Stephen Perez, Erica Hsu, et al.
Citation: BMC Cancer, 24, 592
Date: 05/2024
Type: Document
view details
COVID-19 Vaccines: Moderna and Pfizer-BioNTech Use Varied By Urban, Rural Counties
Examines rural versus urban usage of mRNA COVID-19 vaccines by county. Provides data on first and second dose of vaccines, with data broken down by large central metro, large fringe metro, medium metro, small metro, micropolitan, or noncore location. Includes county-level maps showing Moderna and Pfizer-BioNTech spatial usage and discusses geographic implications that impacted access to each vaccine.
Author(s): Katherine Wen, Daniel A. Harris, Preeti Chachlani, et al.
Citation: Health Affairs, 43(5)
Date: 05/2024
Type: Document
view details
Examines rural versus urban usage of mRNA COVID-19 vaccines by county. Provides data on first and second dose of vaccines, with data broken down by large central metro, large fringe metro, medium metro, small metro, micropolitan, or noncore location. Includes county-level maps showing Moderna and Pfizer-BioNTech spatial usage and discusses geographic implications that impacted access to each vaccine.
Author(s): Katherine Wen, Daniel A. Harris, Preeti Chachlani, et al.
Citation: Health Affairs, 43(5)
Date: 05/2024
Type: Document
view details
Medicare Part D Enrollee Vaccine Use After Elimination of Cost Sharing for Recommended Vaccines in 2023
A report from the Inflation Reduction Act (IRA) Research Series that provides data on Medicare Part D enrollees who received vaccinations after the IRA legislated in 2023 that adult vaccinations recommended by the Advisory Committee on Immunization Practices (ACIP) would be provided at no cost. Includes data breakdowns of total and type of vaccinations received and Medicare Part D enrollee demographic characteristics, such as state and urban versus rural/unknown location.
Author(s): Bisma A. Sayed, Yevgeniy Feyman, Kristen L. King, et al.
Date: 05/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
A report from the Inflation Reduction Act (IRA) Research Series that provides data on Medicare Part D enrollees who received vaccinations after the IRA legislated in 2023 that adult vaccinations recommended by the Advisory Committee on Immunization Practices (ACIP) would be provided at no cost. Includes data breakdowns of total and type of vaccinations received and Medicare Part D enrollee demographic characteristics, such as state and urban versus rural/unknown location.
Author(s): Bisma A. Sayed, Yevgeniy Feyman, Kristen L. King, et al.
Date: 05/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Bridging the Gap in HPV Vaccinations: Community-Driven Strategies in Rural Areas
Discusses development and implementation of an HPV vaccination intervention focused on education and outreach, primary care team training, and data assessment which took place at a Federally Qualified Health Center (FQHC) serving primarily rural and Native American patients in California. Highlights the significance of trust-building and communication efforts to reduce rural vaccine hesitancy.
Author(s): Julie HT Dang
Date: 04/2024
Type: Document
Sponsoring organization: St. Jude Children's Research Hospital
view details
Discusses development and implementation of an HPV vaccination intervention focused on education and outreach, primary care team training, and data assessment which took place at a Federally Qualified Health Center (FQHC) serving primarily rural and Native American patients in California. Highlights the significance of trust-building and communication efforts to reduce rural vaccine hesitancy.
Author(s): Julie HT Dang
Date: 04/2024
Type: Document
Sponsoring organization: St. Jude Children's Research Hospital
view details
What Would Shifting To A Single-Dose HPV Vaccine Mean For Health And Access?
Discusses the potential impact of single-dose human papilloma virus (HPV) vaccines on health disparities for rural residents, lower socioeconomic status patients, men, and sexual and gender minorities. Discusses relief of cost barriers for health systems and vaccine shortages.
Author(s): Matthew Najarian, Amanda F. Petrik
Citation: Health Affairs Forefront
Date: 04/2024
Type: Document
view details
Discusses the potential impact of single-dose human papilloma virus (HPV) vaccines on health disparities for rural residents, lower socioeconomic status patients, men, and sexual and gender minorities. Discusses relief of cost barriers for health systems and vaccine shortages.
Author(s): Matthew Najarian, Amanda F. Petrik
Citation: Health Affairs Forefront
Date: 04/2024
Type: Document
view details
Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023
Reports on COVID-19 bivalent vaccine doses administered by pharmacies participating in the Federal Retail Pharmacy Program (FRPP) from September 1, 2022–September 30, 2023. Includes data on doses administered in urban and rural settings and discusses urban compared to rural contributions of FRPP pharmacies.
Author(s): Roua El Kalach, Nkenge Jones-Jack, Mattie A. Elam, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(13), 286-290
Date: 04/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on COVID-19 bivalent vaccine doses administered by pharmacies participating in the Federal Retail Pharmacy Program (FRPP) from September 1, 2022–September 30, 2023. Includes data on doses administered in urban and rural settings and discusses urban compared to rural contributions of FRPP pharmacies.
Author(s): Roua El Kalach, Nkenge Jones-Jack, Mattie A. Elam, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(13), 286-290
Date: 04/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Retooling Provider HPV Vaccine Communication Styles to Increase Rural HPV Vaccine Coverage
Presents results of a study to assess primary care providers' use of the presumptive recommendation style for HPV vaccination, utilizing data from 2,500 survey responses and 36 semi-structured interviews. Discusses challenges in applying the presumptive recommendation style in rural areas, and describes continuing research on effective HPV vaccine communication.
Author(s): Lisa Spees, Olufeyisayo Odebunmi
Date: 03/2024
Type: Document
Sponsoring organization: St. Jude Children's Research Hospital
view details
Presents results of a study to assess primary care providers' use of the presumptive recommendation style for HPV vaccination, utilizing data from 2,500 survey responses and 36 semi-structured interviews. Discusses challenges in applying the presumptive recommendation style in rural areas, and describes continuing research on effective HPV vaccine communication.
Author(s): Lisa Spees, Olufeyisayo Odebunmi
Date: 03/2024
Type: Document
Sponsoring organization: St. Jude Children's Research Hospital
view details
Who Are Vaccine Champions and What Implementation Strategies Do They Use To Improve Adolescent HPV Vaccination? Findings from a National Survey of Primary Care Professionals
Examines the strategies primary care providers (PCPs) use to improve HPV vaccination rates in their communities. Analyzes issues related to vaccination uptake like quality improvement projects as well as the sharing of information, encouragement, and vaccination data with colleagues. Discusses vaccination issues specific to rural areas and includes data on the likelihood of working with a PCP vaccine champion in a rural location.
Author(s): Micaela K. Brewington, Tara L. Queen, Jennifer Heisler-MacKinnon, et al.
Citation: Implementation Science Communications, 5, 28
Date: 03/2024
Type: Document
view details
Examines the strategies primary care providers (PCPs) use to improve HPV vaccination rates in their communities. Analyzes issues related to vaccination uptake like quality improvement projects as well as the sharing of information, encouragement, and vaccination data with colleagues. Discusses vaccination issues specific to rural areas and includes data on the likelihood of working with a PCP vaccine champion in a rural location.
Author(s): Micaela K. Brewington, Tara L. Queen, Jennifer Heisler-MacKinnon, et al.
Citation: Implementation Science Communications, 5, 28
Date: 03/2024
Type: Document
view details
HPV ECHO for Providers: Strengthening Opportunities to Increase HPV Vaccination Coverage in Rural Primary Care
Discusses a study using the Extension for Community Healthcare Outcomes (ECHO) Model to train rural primary care clinics to deliver evidence-based human papillomavirus (HPV) vaccine communication to rural families in Pennsylvania. Highlights initial findings related to communication strategy and effectiveness.
Author(s): William A. Calo, Josheili Y. Llavona-Ortiz
Date: 02/2024
Type: Document
Sponsoring organization: St. Jude Children's Research Hospital
view details
Discusses a study using the Extension for Community Healthcare Outcomes (ECHO) Model to train rural primary care clinics to deliver evidence-based human papillomavirus (HPV) vaccine communication to rural families in Pennsylvania. Highlights initial findings related to communication strategy and effectiveness.
Author(s): William A. Calo, Josheili Y. Llavona-Ortiz
Date: 02/2024
Type: Document
Sponsoring organization: St. Jude Children's Research Hospital
view details
Human Papillomavirus Vaccination Coverage in Children Ages 9–17 Years: United States, 2022
Offers parent-reported data on the percentage of children 9-17 years of age who received at least one dose of the HPV (human papillomavirus) vaccine. Includes date for metropolitan and nonmetro areas.
Author(s): Maria A. Villarroel, Adena M. Galinsky, Peng-Jun Lu, Cassandra Pingali
Date: 02/2024
Type: Document
Sponsoring organization: National Center for Health Statistics
view details
Offers parent-reported data on the percentage of children 9-17 years of age who received at least one dose of the HPV (human papillomavirus) vaccine. Includes date for metropolitan and nonmetro areas.
Author(s): Maria A. Villarroel, Adena M. Galinsky, Peng-Jun Lu, Cassandra Pingali
Date: 02/2024
Type: Document
Sponsoring organization: National Center for Health Statistics
view details